REFERENCES
- Shargel L, Wu-pong S, Andrew BC. Applied Biopharmaceutics & Pharmacokinetics5th. McGraw Hill Medical. 2005; 391–392
- Melander A. Influence of food on the bioavailability of drugs. Clin. Pharmacokinet. 1978; 3: 337–351
- Welling PG. Influence of food and diet on GI drug absorption: A review. J. Pharmacokinet. Pharmacodyn. 1977; 5: 291–334
- Welling PG, Huang H, Koch PA, Craig WA, Madsen PO. Bioavailability of amoxicillin and ampicillin in fasted and non-fasted subjects. J. Pharm. Sci. 1977; 66: 549–552
- Amoxil. Physicians Desk Reference57th. Thompson. 2003; 1315–1318
- Fred NE, Daniel AS. Pharmacokinetics of amoxicillin and ampicillin: crossover study of the effect of food, antimicrob. Agents and Chemother. 1978; 14: 539–543
- Abreu LRPD, Ortiz RAM, Castro SCD, Pedrazzoli J. HPLC determination of amoxicillin comparative bioavailability in healthy volunteers after a single dose administration. J. Pharma. Pharmaceutical. Sciences. 2003; 6: 223–220
- Arancibia A, Gutamann J, Gonzalez G, Gonzalez C. Absorption and disposition kinetics of amoxicillin in normal human subjects, antimicrob. Agents and Chemother. 1980; 7: 199–202
- Bodey G, Nance J. Amoxicillin: in vitro and pharmacological studies. J. Antimicrob. Agents Chemother. 1972; 1: 358–362
- Brundusino A, Vasconcellos LH, Pinto DSB, Oliani C. Randomized crossover pharmacokinetic study with two oral amoxicillin pharmaceutical forms (tablets and capsules) at three different dosages. Eu. Bulletin of Drug Res. 1999; 7: 5–11
- Croydon EAP, Sutherland R. Alpha-amino-p-hydroxyl-benzylpenicillin (BRL-2333): A New semisynthetic penicillin. Antimicrob. Agents Chemother. 1970; 427–433
- Gordon RC, Regamey C, Kirby WMM. Comparative clinical pharmacology of amoxicillin and ampicillin administered orally. Antimicrob Agents Chemother. 1972; 1: 504–507
- Kosmidis J, Willians D, Andrews J. Amoxicillin—pharmacology, bacteriology, and clinical studies. British. J. Clin. Pract. 1972; 26: 341–346
- Kurtz GS, Ribeiro FM, Vicente FL, Struchine CJ. Development and validation of limited-sampling strategies for predicting amoxicillin pharmacokinetic and pharmacodynamic parameters. Antimicrobial Agents and Chemotherapy. 2001; 45: 3029–3036
- Neu HC. Amoxicillin. Ann. Int. Med. 1979; 90: 356–360
- Odenholt I, Cars O, Löwdin E. Pharmacodynamic studies of amoxicillin against Streptococcus pneumoniae: comparison of a new pharmacokinetically enhanced formulation (2000 mg twice daily) with standard dosage regimens. The British Society for Antimicrobial Chemotherapy. 2004; 54: 1062–1066
- Oliveira CH, Abib E, Vannuchi YB, Sucupira M, Ilha J, Nucci DG. Comparative bioavailability of 4 amoxicillin formulations in healthy volunteers after single dose administration. Int J. Clin. Pharmacol. Ther. 2001; 39: 167–172
- Philipson A, Sabath LD, Rosner B. Sequence effect on ampicillin blood levels noted in an amoxicillin, ampicillin, and epicillin crossover study. Antimicrob. Agents Chemother. 1975; 8: 311–320
- Spyker DA, Ramond JR, Vann RL, Obrien WM. Pharmacokinetics of amoxicillin: dose dependence after IV, PO, and IM administration. Antimicrob. Agents Chemother. 1977; 11: 132–141
- Ginsburg CM, Cracken GHM, Thomas ML, Clahsen J. Comparative pharmacokinetics of amoxicillin and ampicillin in infants and children. Pediatrics. 1979; 64: 627–631
- Baglie S, Rosalen PL, Franco LM, Ruenis AP, Baglie RC, Franco GC, Silva P, Groppo FC. Comparative bioavailability of 875 mg amoxicillin tablets in healthy human volunteers. Int. J. Clin. Pharmacol. Ther. 2005; 43: 350–354
- Thiessen JJ. Bioavailability and Bioequivalence. University of Toranto, Canada
- Jacobs MR. Optimization of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters. Clinic. Microb. and Infec. 2001; 7: 589–596
- Berry V, Jennings K, Woodnutt G. Bactericidal and morphological effect of amoxicillin on Halicobacter pylori. Antimicrobial Agents and Chemotherapy. 1995; 39: 1859–1861